RecruitingNot ApplicableNCT06176248

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis: a Randomized Controlled Superiority Trial

Sponsor

CHU de Reims

Enrollment

62 participants

Start Date

Oct 11, 2024

Study Type

INTERVENTIONAL

Conditions

Adhesive Capsulitis

Summary

This is a double-blind interventional superiority study evaluating the efficacy of suprascapular nerve block in addition to conventional therapies for adhesive capsulitis. Adhesive capsulitis is a pathology that results in reduced shoulder mobility due to retraction of the periarticular capsule. It may be primary or secondary to traumatic or neurological events, or associated with diabetes in particular. The usual treatment includes re-education sessions to improve joint amplitude and restore shoulder mobility. In persistent forms, intra-articular injection of cortisone is combined with distension of the capsule with a local anaesthetic under radiographic control. In some countries, subscapular nerve block (reversible anaesthesia) is used to improve pain. The combination of arthrodistension and subscapular nerve block has never been performed to accelerate the healing process. The aim of this study is to compare the performance of these two procedures together against the reference technique alone on time to improvement with the number of patients improved at one month according to the Constant score. This score is used to assess shoulder pain and function, with a significant improvement above eight points.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or abduction in relation to the contralateral shoulder.
Patient over 18 years of age
Patient covered by a social security scheme
Presence of an accompanying person on the day of the procedure for the return trip
Patient having signed the consent form to participate in the study

Exclusion Criteria7

Patient protected by law
Pregnant women
Patient who has had shoulder surgery less than six months old
Patient unable to undergo rehabilitation within one month of surgery
Allergy to one of the products used (anesthetic, iodinated contrast medium)
Neuro-orthopedic disorder hampering clinical recovery
Hemostasis disorder contraindicating block (no discontinuation of anticoagulants according to SFAR recommendations, congenital hemostasis disorder)

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTriamcinolone Acetonide

1 injection of local anaesthetic (5 ml levobupivacaine 2.5 mg/mL) opposite the subscapular nerve, under ultrasound control, in a lateral decubitus or sitting position. Subsequently, they underwent Xray-controlled arthrodistension by injection of 1 ml of Triamcinolone Acetonide, combined with 10 ml of visipaque 270 contrast medium and 5 ml of Xylocaine.

DRUGsaline solution

intramuscular injection of 1 ml saline under ultrasound control under the same conditions as the experimental group. Subsequently, they will undergo Xray-controlled arthrodistension under the same conditions as the experimental group